Tue 1 July 2025
Warszawa (PL)
24/12°C
| Mon | Tue | Wed | Thu | Fri |
|---|---|---|---|---|
| 23 | 27 | 29 | 35 | 22 |
Tue 1 July 2025
Praha (CZ)
31/17°C
| Mon | Tue | Wed | Thu | Fri |
|---|---|---|---|---|
| 31 | 34 | 35 | 36 | 28 |
Tue 1 July 2025
Bratislava (SK)
30/15°C
| Mon | Tue | Wed | Thu | Fri |
|---|---|---|---|---|
| 32 | 31 | 33 | 35 | 31 |
Tue 1 July 2025
Budapest (HU)
29/21°C
| Mon | Tue | Wed | Thu | Fri |
|---|---|---|---|---|
| 34 | 33 | 32 | 36 | 34 |
State drugs authority recommends anti-COVID drug from Regeneron
February 16th, 2021
The Czech State Drugs Control Institute (SUKL) recommended an anti-coronavirus drug by the Regeneron company to be used in Czechia even though it has not been registered yet, SUKL director Irena Storova tweeted today. The drug is based on a combination of two monoclonal antibodies, Casirivimab and Imdevimab. It is meant for high-risk outpatients. A week ago, the SUKL recommended the first monoclonal-based drug from the U.S. Eli Lilly firm and its usage was approved by the Health Ministry, too, some days after.
CTK